Newsroom

RIAD, Arabia Saudita--(BUSINESS WIRE)--Red Sea Global (RSG), el desarrollador de turismo regenerativo, inauguró Jayasom Wellness Resort AMAALA para sumar una oferta de salud holística distintiva al destino. Diseñado por Heah & Co. y con interiores de Studio Carter, Jayasom Wellness Resort AMAALA está ubicado en la ensenada más grande de Triple Bay, e incluye 153 cayos en 24 residencias. El resort forma parte del polo de bienestar aislado de AMAALA en la costa del Mar Rojo, donde la naturale...

CARNEGIE, Pa.--(BUSINESS WIRE)--Ampco-Pittsburgh Corporation (NYSE: AP) (The “Corporation”) announced today that Brett McBrayer, Ampco Chief Executive Officer, David Anderson, Ampco Vice President and Chief Financial Officer and President of Air and Liquid Systems, and Sam Lyon, President of Union Electric Steel, will present at the Sidoti Small-Cap Virtual Investor Conference September 23, 2026. The Corporation’s presentation is scheduled to begin at 1:45 pm ET followed by a Q&A session wi...

SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that Greg Ciongoli has been appointed to the Company's Board of Directors, effective September 16, 2026. Mr. Ciongoli will also serve as a member of the Audit Committee. Mr. C...

MAYODAN, N.C.--(BUSINESS WIRE)--Sturm, Ruger & Company, Inc. (NYSE: RGR) (“Ruger” or the “Company”) today announced that the applicable regulatory conditions under its previously announced Strategic Cooperation Agreement (“Agreement”) with Beretta Holding S.A. (“Beretta Holding”) have been satisfied. Therefore, consistent with the terms of the Agreement, the Company’s Board of Directors (the “Board”) has unanimously approved an amendment (the “Amendment”) to the Company’s shareholder rights...

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on September 15, 2026, it granted stock options to purchase an aggregate of 53,175 shares of common stock to ni...

MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce aujourd’hui que le partenariat stratégique précédemment annoncé avec Sobi est désormais en vigueur, à la suite de l’expiration des délais d’attente applicables auprès des autorités de la concurrence et de la réalisation d’autres conditions. Comme annoncé le 10 août 2026, Innate Pharma a conclu un partenariat stratégique avec Sobi pour l’attribution...

MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that the previously announced strategic partnership with Sobi is now effective following the expiration of applicable antitrust waiting periods and completion of other conditions. As announced on August 10, 2026, Innate Pharma entered a strategic partnership with Sobi to license lacutamab in T-cell lymphoma. Transaction closing triggers the USD 75...

NEW YORK--(BUSINESS WIRE)--Vishal Garg, founder and former CEO of Better Home & Finance Corporation (“Better” or the “Company”) (Nasdaq: BETR) and significant stockholder, today announced that leading independent proxy advisory firm, Egan-Jones Proxy Services (“Egan-Jones”), has recommended shareholders vote FOR both of the Garg Group’s proposals on the GREEN consent card, including the removal of five directors on Better’s Board of Directors (the “Board”). Mr. Garg commented: “We appreciat...

MOUNTAIN VIEW, Califórnia--(BUSINESS WIRE)--A Rubedo Life Sciences, Inc. (Rubedo) anunciou hoje um novo estudo clínico com o composto experimental RLS-1496 em pacientes com alopecia androgenética (AGA), com início previsto para outubro de 2026 e dados iniciais esperados para o primeiro semestre de 2027. O estudo marca a primeira avaliação clínica de um modulador de GPX4 para a perda de cabelo, ampliando o programa que estabeleceu o RLS-1496 como o primeiro modulador de GPX4 do mundo a entrar em...

سول، كوريا الجنوبية--(BUSINESS WIRE)--أعلنت Rebellions، الشركة الرائدة عالميًا في مجال البنية التحتية لاستدلال الذكاء الاصطناعي، وai&، شركة عالمية متكاملة رأسيًا في تقنيات الذكاء الاصطناعي، عن شراكة لنشر أنظمة RebelRack من Rebellions ضمن البنية التحتية المتنوعة لموارد الحوسبة لدى ai&، وذلك في إطار خدمة استدلال الذكاء الاصطناعي التي تقدمها الشركة في اليابان. وستتيح هذه الشراكة للشركات والمؤسسات الحكومية والمطورين إمكانية الوصول إلى خدمات استدلال مدعومة بتقنيات Rebellions ومنشورة داخل اليا...